May 13, 2020: Prodrome Sciences is continuing operations during COVID-19. Our top priority is the safety and well-being of our employees, suppliers, and customers.

Alzheimer's research published

July 8, 2019

Prodrome Sciences publishes research on the relationship between plasmalogens and the APOE e4 genotype

Our published research shows that a person's levels of plasmalogens, a critical lipid molecule required for brain and nerve function, is a better indicator of risk of Alzheimer's disease than the established genetic risk factor APOE e4. This research further emphasizes the need for a plasmalogen blood test to assess risk of Alzheimer's disease as well as a safe and natural plasmalogen supplement to increase levels of plasmalogens.

Click here to view the publication.

To view a video of Dr. Goodenowe explaining how plasmalogen levels and the APOE genotype affect your risk of dementia click here.

Keep in touch

©2021 Prodrome Sciences Inc.